Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

More Deals for Venturepharm

publication date: Aug 25, 2008

Venturepharm Group has established a collaboration with Canadian biotech Lorus Therapeutics to develop Lorus’ portfolio of cancer drugs. Lorus has eight molecules in its pipeline. Venturepharm also announced that it has absorbed Acesys Pharmatech, a Nanjing global drug discovery CRO with about 70 chemists, into its China-located Exelgen operation. More details...

Stock Symbols: (AMEX: LRP) (HKSE: 8225) (NSDQ: CBTE)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital